Jurgen or David, do you have anything to add?

No, I think that's a very good summary overall, Jenny, and it was really good that you were the main drive behind putting that forward.

And I think what we were trying to do from our group is explore the similarities in how we were setting ourselves up, and also where are maybe some of the differences.

For example, I work both in a large pharma setup and in a CRO setup, and there's a lot of similarities in the sense that people in these groups have a sort of really deep methodological background in there.

But their focus areas, they may be slightly different.

So in a CRO setup, it is typically focusing on client concerns to try and help them speed up maybe stages of development with innovative approaches.

In a large pharma setting, that's maybe then targeting specific therapeutic areas more, the areas that the company is working in.

I feel that's a particular strength of working in a methodology group.